Immediate Impact
1 from Science/Nature 52 standout
Citing Papers
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery
2025 Standout
Works of Cuixia Gao being referenced
Efficacy and safety of liposomal mitoxantrone (Lipo-MIT) in advanced breast cancer (ABC): A randomized, open label, active-controlled, single-center, phase II clinical trial.
2020
Highly frequent promoter methylation and PIK3CA amplification in non-small cell lung cancer (NSCLC)
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Cuixia Gao | 148 | 149 | 18 | 50 | 19 | 351 | |
| Lin Zhao | 75 | 128 | 22 | 121 | 19 | 344 | |
| Hidenori Nishida | 72 | 200 | 24 | 80 | 14 | 402 | |
| Nikola Radović | 170 | 157 | 30 | 28 | 14 | 390 | |
| Xiaolong Zhao | 119 | 125 | 58 | 17 | 32 | 387 | |
| Ke He | 86 | 92 | 23 | 25 | 20 | 324 | |
| Xinggu Lin | 38 | 156 | 10 | 31 | 21 | 367 | |
| Sun Ha Lee | 70 | 152 | 25 | 28 | 14 | 400 | |
| Chen Liu | 48 | 145 | 12 | 22 | 19 | 395 | |
| Shang‐Sen Lee | 76 | 88 | 9 | 59 | 22 | 379 | |
| Ziyang Huang | 91 | 98 | 48 | 32 | 32 | 384 |
All Works
Loading papers...